Imaging of hepatocellular carcinoma: Current concepts

Recent Results in Cancer Research

Volumn 190, Issue , 2013, Pages 33-55

  Parikh, Ankur ^a   Taouli, Bachir ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; CT; Hepatocellular carcinoma; MR imaging; US

Indexed keywords

ALPHA FETOPROTEIN; CONTRAST MEDIUM; GADOBENIC ACID; GADOXETIC ACID; IODINATED POPPYSEED OIL; SORAFENIB;

ALCOHOL LIVER CIRRHOSIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CELL PROLIFERATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOABLATION; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DOPPLER FLOWMETRY; EARLY DIAGNOSIS; ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HEMANGIOMA; LIVER NODULE; LIVER PARENCHYMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THERMOCOAGULATION;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; EARLY DETECTION OF CANCER; HEMANGIOMA; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868322932     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16037-0_3     Document Type: Article

References (106)

1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557-2576 (Pubitemid 46890874)
2. Parkin DM, Bray F, Ferlay J (2002) Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55(2):74-108
3. Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9):1485-1491
4. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45(4):529-538 (Pubitemid 44307383)
5. Ahn J, Flamm SL (2004) Hepatocellular carcinoma. Dis Mon 50(10):556-573 (Pubitemid 39643396)
6. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Nonomura A, Nakanuma Y (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172(4):969-976 (Pubitemid 29505622)
7. Sakamoto M, Hirohashi S, Shimosato Y (1991) Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22(2):172-178
8. Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H (2006) Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer 106(3):636-647 (Pubitemid 43157628)
9. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M (2002) Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 225(1):143-149
10. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340(10):745-750 (Pubitemid 29114292)
11. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693-699 (Pubitemid 26079803)
12. Wu JT (1990) Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review. Ann Clin Lab Sci 20(2):98-105 (Pubitemid 20086554)
13. Sherman M, Peltekian KM, Lee C (1995) Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 22(2):432-438
14. Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130(7):417-422
15. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208-1236. doi:10.1002/hep.20933 (Pubitemid 43112690)
16. Lencioni R, Pinto F, Armillotta N, Bartolozzi C (1996) Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 201(2):353-358 (Pubitemid 26357625)
17. Gaiani S, Volpe L, Piscaglia F, Bolondi L (2001) Vascularity of liver tumours and recent advances in Doppler ultrasound. J Hepatol 34(3):474-482 (Pubitemid 32240830)
18. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, Maraschi A, Fiorelli G, Fargion S (2001) Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology 34(6):1109-1112 (Pubitemid 33096582)
19. Lencioni R, Mascalchi M, Caramella D, Bartolozzi C (1996) Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging 21(1):41-48
20. Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, Brown JJ, McFarland EG, Middleton WD, Balfe DM, Ritter JH (2003) Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 226(2):533-542 (Pubitemid 36313446)
21. Wilson SR, Jang HJ, Kim TK, Iijima H, Kamiyama N, Burns PN (2008) Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol 190(3):691-695 (Pubitemid 351304513)
22. Ding H, Wang WP, Huang BJ, Wei RX, He NA, Qi Q, Li CL (2005) Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 24(3):285-297 (Pubitemid 40315955)
23. Tombesi P, Catellani M, Abbasciano V, Sartori S, Tassinari D (2008) Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med 27(6):991-992 (Pubitemid 351913842)
24. Lanka B, Jang HJ, Kim TK, Burns PN, Wilson SR (2007) Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med 26(12):1703-1714 (Pubitemid 350210078)
25. Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C (1999) Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT - a comparative study. Radiology 212(3):866-875 (Pubitemid 29410995)
26. Lee KH, O'Malley ME, Haider MA, Hanbidge A (2004) Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol 182(3):643-649 (Pubitemid 38269524)
27. Schima W, Hammerstingl R, Catalano C, Marti-Bonmati L, Rummeny EJ, Montero FT, Dirisamer A, Westermayer B, Bellomi M, Brisbois D, Chevallier P, Dobritz M, Drouillard J, Fraioli F, Jesus Martinez M, Morassut S, Vogl TJ (2006) Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. AJR Am J Roentgenol 186(6):1571-1579 (Pubitemid 46112519)
28. Kim SK, Lim JH, Lee WJ, Kim SH, Choi D, Lee SJ, Lim HK, Kim H (2002) Detection of hepatocellular carcinoma: comparison of dynamic three-phase computed tomography images and four-phase computed tomography images using multidetector row helical computed tomography. J Comput Assist Tomogr 26(5):691-698 (Pubitemid 35423369)
29. Laghi A, Iannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F, Nofroni I, Passariello R (2003) Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226(2):543-549 (Pubitemid 36313447)
30. Murakami T, Kim T, Kawata S, Kanematsu M, Federle MP, Hori M, Okada A, Kumano S, Sugihara E, Tomoda K, Nakamura H (2003) Evaluation of optimal timing of arterial phase imaging for the detectionofhypervascular hepatocellular carcinoma byusing triple arterial phase imaging with multidetector-row helical computed tomography. Invest Radiol 38(8):497-503 (Pubitemid 36875546)
31. Lim JH, Choi D, Kim SH, Lee SJ, Lee WJ, Lim HK, Kim S (2002) Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. AJR Am J Roentgenol 179(1):67-73 (Pubitemid 34694813)
32. Sommer CM, Schwarzwaelder CB, Stiller W, Schindera ST, Stampfl U, Bellemann N, Holzschuh M, Schmidt J, Weitz J, Grenacher L, Kauczor HU, Radeleff BA (2011) Iodine removal in intravenous dual-energy CT-cholangiography: is virtual non-enhanced imaging effective to replace true non-enhanced imaging? Eur J Radiol 81(4):692-699
33. Zhang LJ, Peng J, Wu SY, Wang ZJ, Wu XS, Zhou CS, Ji XM, Lu GM (2010) Liver virtual non-enhanced CT with dual-source, dual-energy CT: a preliminary study. Eur Radiol 20(9):2257-2264
34. Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD (1996) Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 20(3):337-342 (Pubitemid 26142280)
35. Stevens WR, Johnson CD, Stephens DH, Batts KP (1994) CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology 191(2):531-537 (Pubitemid 24141063)
36. Hollett MD, Jeffrey RB Jr, Nino-Murcia M, Jorgensen MJ, Harris DP (1995) Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (
37. Baron RL, Oliver JH 3rd, Dodd GD 3rd, Nalesnik M, Holbert BL, Carr B (1996) Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199(2):505-511 (Pubitemid 26122003)
38. Oliver JH 3rd, Baron RL, Federle MP, Rockette HE Jr (1996) Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 167(1):71-77
39. Hwang GJ, Kim MJ, Yoo HS, Lee JT (1997) Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 202(2):383-388 (Pubitemid 27051731)
40. Lee HM, Lu DS, Krasny RM, Busuttil R, Kadell B, Lucas J (1997) Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. AJR Am J Roentgenol 169(1):125-130 (Pubitemid 27289621)
41. Kanematsu M, Oliver JH 3rd, Carr B, Baron RL (1997) Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography. Radiology 205(1):75-80 (Pubitemid 27415128)
42. Miller FH, Butler RS, Hoff FL, Fitzgerald SW, Nemcek AA Jr, Gore RM (1998) Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms. AJR Am J Roentgenol 171(3):643-649 (Pubitemid 28406124)
43. Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV (2010) Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254(1):154-162
44. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28(3):747-769
45. Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK (2003) Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging 18(2):189-195 (Pubitemid 36935950)
46. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 202(1):268-273 (Pubitemid 27024138)
47. Cruite I, Schroeder M, Merkle EM, Sirlin CB (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195(1):29-41
48. Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195(1):13-28
49. Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254(1):47-66
50. Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11(2):102-125
51. Ramalho M, Altun E, Heredia V, Zapparoli M, Semelka R (2007) Liver MR imaging: 1.5 T versus 3 T. Magn Reson Imaging Clin N Am 15(3):321-347
52. Merkle EM, Dale BM, Paulson EK (2006) Abdominal MR imaging at 3 T. Magn Reson Imaging Clin N Am 14(1):17-26
53. Hecht EM, Lee RF, Taouli B, Sodickson DK (2007) Perspectives on body MR imaging at ultrahigh field. Magn Reson Imaging Clin N Am 15(3):449-465 (Pubitemid 47430005)
54. Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192(6):1675-1681
55. Kadoya M, Matsui O, Takashima T, Nonomura A (1992) Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 183(3):819-825
56. Honda H, Kaneko K, Kanazawa Y, Hayashi T, Fukuya T, Matsumata T, Maeda T, Masuda K (1997) MR imaging of hepatocellular carcinomas: effect of Cu and Fe contents on signal intensity. Abdom Imaging 22(1):60-66 (Pubitemid 27030218)
57. Honda H, Onitsuka H, Kanazawa Y, Matsumata T, Hayashi T, Kaneko K, Fukuya T, Tateshi Y, Adachi E, Masuda K (1995) MR imaging of hepatocellular carcinoma. Correlation of metal content and signal intensity. Acta Radiol 36(2):163-167
58. Earls JP, Theise ND, Weinreb JC, DeCorato DR, Krinsky GA, Rofsky NM, Mizrachi H, Teperman LW (1996) Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201(1):207-214 (Pubitemid 26314389)
59. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, Gabata T, Takashima T, Nakanuma Y, Terada T, Ida M (1989) Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 173(1):123-126 (Pubitemid 19242418)
60. Mitchell DG, Palazzo J, Hann HW, Rifkin MD, Burk DL Jr, Rubin R (1991) Hepatocellular tumors with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15(5):762-769
61. Mitchell DG, Rubin R, Siegelman ES, Burk DL Jr, Rifkin MD (1991) Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 178(1):101-103
62. Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR (2004) T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 230(3):637-644 (Pubitemid 38252856)
63. Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, West AB, Babb JS, Taouli B, Lee VS, Krinsky GA (2006) Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MRimaging as a stand-alone sequence for diagnosis. Radiology 239(2):438-447
64. Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Aisen AM (2009) The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 16(10):1208-1214
65. Miller FH, Hammond N, Siddiqi AJ, Shroff S, Khatri G, Wang Y, Merrick LB, Nikolaidis P (2010) Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 32(1):138-147
66. Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V (2010) New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Hepatol 55(1):126-132
67. Oi H, Murakami T, Kim T, Matsushita M, Kishimoto H, Nakamura H (1996) Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AJR Am J Roentgenol 166(2):369-374 (Pubitemid 26037293)
68. Kim T, Murakami T, Oi H, Matsushita M, Kishimoto H, Igarashi H, Nakamura H, Okamura J (1995) Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr 19(6):948-954
69. Yoon SH, Lee JM, So YH, Hong SH, Kim SJ, Han JK, Choi BI (2009) Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol 193(6):W482-489
70. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020-1022
71. Imaeda T, Kanematsu M, Mochizuki R, Goto H, Saji S, Shimokawa K (1994) Extracapsular invasion of small hepatocellular carcinoma: MR and CT findings. J Comput Assist Tomogr 18(5):755-760 (Pubitemid 24286368)
72. Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR Am J Roentgenol 196(5):1083-1089
73. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D (2007) Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 17(10):2519-2530
74. Lupescu IG, Capsa RA, Gheorghe L, Herlea V, Georgescu SA (2008) Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules. J Gastrointestin Liver Dis 17(3):341-346
75. Di Martino M, Marin D, Guerrisi A, Baski M, Galati F, Rossi M, Brozzetti S, Masciangelo R, Passariello R, Catalano C (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology 256(3):806-816
76. Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI (2008) Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol 191(2):529-536
77. Madhoun MF, Fazili J, Bright BC, Bader T, Roberts DN, Bronze MS (2010) Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci 339(2):169-173. doi:10.1097/MAJ.0b013e3181c4af27
78. Liu S, Chan KW, Wang B, Qiao L (2009) Fibrolamellar hepatocellular carcinoma. Am J Gastroenterol 104(10):2617-2624 quiz 2625
79. Mendizabal M, Reddy KR (2009) Current management of hepatocellular carcinoma. Med Clin North Am 93(4):885-900
80. Kloeckner R, Otto G, Biesterfeld S, Oberholzer K, Dueber C, Pitton MB (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33(3):532-540
81. De Santis M, Alborino S, Tartoni PL, Torricelli P, Casolo A, Romagnoli R (1997) Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 7(1):10-16 (Pubitemid 127538512)
82. Semelka RC, Worawattanakul S, Mauro MA, Bernard SA, Cance WG (1998) Malignant hepatic tumors: changes on MRI after hepatic arterial chemoembolization - preliminary findings. J Magn Reson Imaging 8(1):48-56 (Pubitemid 28099558)
83. Kim S, Mannelli L, Hajdu CH, Babb JS, Clark TW, Hecht EM, Taouli B (2010) Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction. J Magn Reson Imaging 31(2):348-355
84. Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B (2009) Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol 193(4):1044-1052
85. Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF (2003) Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 181(3):708-710 (Pubitemid 37021839)
86. Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF (2006) The role offunctional MR imaginginthe assessmentoftumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 17(3):505-512 (Pubitemid 44318722)
87. Solbiati L, Ierace T, Tonolini M, Cova L (2004) Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51(Suppl):S19-23 (Pubitemid 38845009)
88. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88(11):2452-2463 (Pubitemid 30331950)
89. Khankan AA, Murakami T, Onishi H, Matsushita M, Iannaccone R, Aoki Y, Tono T, Kim T, Hori M, Osuga K, Passariello R, Nakamura H (2008) Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging 27(3):546-551 (Pubitemid 351354739)
90. Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223(1):255-262 (Pubitemid 34258217)
91. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378-390
92. Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC (1998) Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging - a case report. Radiology 209(2):461-464 (Pubitemid 28503114)
93. Krinsky GA, Lee VS, Nguyen MT, Rofsky NM, Theise ND, Morgan GR, Teperman LW, Weinreb JC (2001) Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 218(1):47-53 (Pubitemid 32151271)
94. Krinsky GA, Lee VS, Nguyen MT, Rofsky NM, Theise ND, Morgan GR, Teperman LW, Weinreb JC (2000) Siderotic nodules at MR imaging: regenerative or dysplastic? J Comput Assist Tomogr 24(5):773-776 (Pubitemid 32204309)
95. Krinsky GA, Israel G (2003) Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation. AJR Am J Roentgenol 180(4):1023-1027 (Pubitemid 36363044)
96. Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L (2011) Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (
97. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N (2003) Cirrhosis or chronic hepatitis: evaluation of small (
98. Kanematsu M, Kondo H, Semelka RC, Matsuo M, Goshima S, Hoshi H, Moriyama N, Itai Y (2003) Early-enhancing non-neoplastic lesions on gadolinium-enhanced MRI of the liver. Clin Radiol 58(10):778-786
99. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS (2000) Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 217(3):750-756
100. Jeong YY, Mitchell DG, Kamishima T (2002) Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178(6):1327-1334 (Pubitemid 34547809)
101. Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA (2005) Importance of small (
102. Brancatelli G, Federle MP, Blachar A, Grazioli L (2001) Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 219(1):69-74 (Pubitemid 32234053)
103. Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL (2008) Magnetic resonance imaging of hepaticfibrosis: emerging clinical applications. Hepatology 47(1):332-342 (Pubitemid 351171070)
104. Villanueva A, Llovet JM (2011) Targeted therapies for hepatocellular carcinoma. Gastroenterology 140(5):1410-1426
105. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48(4):1312-1327. doi:10.1002/hep.22506
106. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM (2010) Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 30(1):35-51